These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 14727370

  • 21. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
    Théberge J, Al-Semaan Y, Drost DJ, Malla AK, Neufeld RW, Bartha R, Manchanda R, Menon R, Densmore M, Schaefer B, Williamson PC.
    Psychiatry Res; 2004 Jul 30; 131(2):107-14. PubMed ID: 15313517
    [Abstract] [Full Text] [Related]

  • 22. Posterior cingulate gyrus metabolic changes in chronic schizophrenia with generalized cognitive deficits.
    Shimizu E, Hashimoto K, Ochi S, Fukami G, Fujisaki M, Koike K, Okamura N, Ohgake S, Koizumi H, Matsuzawa D, Zhang L, Watanabe H, Nakazato M, Shinoda N, Komatsu N, Morita F, Iyo M.
    J Psychiatr Res; 2007 Jul 30; 41(1-2):49-56. PubMed ID: 15993895
    [Abstract] [Full Text] [Related]

  • 23. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study.
    Blasi G, Bertolino A, Brudaglio F, Sciota D, Altamura M, Antonucci N, Scarabino T, Weinberger DR, Nardini M.
    Psychiatry Res; 2004 Jul 30; 131(2):95-105. PubMed ID: 15313516
    [Abstract] [Full Text] [Related]

  • 24. Investigating the neuropsychological and neuroanatomical changes that occur over the first 2-3 years of illness in patients with first-episode schizophrenia.
    Zipparo L, Whitford TJ, Redoblado Hodge MA, Lucas S, Farrow TF, Brennan J, Gomes L, Williams LM, Harris AW.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):531-8. PubMed ID: 18061326
    [Abstract] [Full Text] [Related]

  • 25. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
    Szulc A, Galinska B, Tarasow E, Waszkiewicz N, Konarzewska B, Poplawska R, Bibulowicz D, Simonienko K, Walecki J.
    Pharmacopsychiatry; 2011 Jun 15; 44(4):148-57. PubMed ID: 21710405
    [Abstract] [Full Text] [Related]

  • 26. Measuring mania metabolites: a longitudinal proton spectroscopy study of hypomania.
    Malhi GS, Ivanovski B, Wen W, Lagopoulos J, Moss K, Sachdev P.
    Acta Psychiatr Scand Suppl; 2007 Jun 15; (434):57-66. PubMed ID: 17688464
    [Abstract] [Full Text] [Related]

  • 27. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
    Glodzik-Sobanska L, Slowik A, McHugh P, Sobiecka B, Kozub J, Rich KE, Urbanik A, Szczudlik A.
    Psychiatry Res; 2006 Dec 01; 148(2-3):111-20. PubMed ID: 17088051
    [Abstract] [Full Text] [Related]

  • 28. Quantitative proton MR spectroscopic imaging of the mesial temporal lobe.
    Arslanoglu A, Bonekamp D, Barker PB, Horská A.
    J Magn Reson Imaging; 2004 Nov 01; 20(5):772-8. PubMed ID: 15503328
    [Abstract] [Full Text] [Related]

  • 29. Neuronal dysfunction of the frontal lobe in schizophrenia.
    Pae CU, Choe BY, Joo RH, Lim HK, Kim TS, Yoo SS, Choi BG, Kim JJ, Lee SJ, Lee C, Paik IH, Lee CU.
    Neuropsychobiology; 2004 Nov 01; 50(3):211-5. PubMed ID: 15365217
    [Abstract] [Full Text] [Related]

  • 30. Prediction of cognitive decline after stroke using proton magnetic resonance spectroscopy.
    Ross AJ, Sachdev PS, Wen W, Brodaty H, Joscelyne A, Lorentz LM.
    J Neurol Sci; 2006 Dec 21; 251(1-2):62-9. PubMed ID: 17092517
    [Abstract] [Full Text] [Related]

  • 31. Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study.
    Sung YH, Cho SC, Hwang J, Kim SJ, Kim H, Bae S, Kim N, Chang KH, Daniels M, Renshaw PF, Lyoo IK.
    Drug Alcohol Depend; 2007 Apr 17; 88(1):28-35. PubMed ID: 17084995
    [Abstract] [Full Text] [Related]

  • 32. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
    Chen CS, Chiang IC, Li CW, Lin WC, Lu CY, Hsieh TJ, Liu GC, Lin HF, Kuo YT.
    Psychiatry Res; 2009 Jun 30; 172(3):210-4. PubMed ID: 19303260
    [Abstract] [Full Text] [Related]

  • 33. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.
    Vagnozzi R, Signoretti S, Tavazzi B, Floris R, Ludovici A, Marziali S, Tarascio G, Amorini AM, Di Pietro V, Delfini R, Lazzarino G.
    Neurosurgery; 2008 Jun 30; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995
    [Abstract] [Full Text] [Related]

  • 34. Lithium does not alter the choline/creatine ratio in the temporal lobe of human volunteers as measured by proton magnetic resonance spectroscopy.
    Silverstone PH, Hanstock CC, Rotzinger S.
    J Psychiatry Neurosci; 1999 May 30; 24(3):222-6. PubMed ID: 10354656
    [Abstract] [Full Text] [Related]

  • 35. Chronic temporal lobe epilepsy: spatial extent and degree of metabolic dysfunction studied with magnetic resonance spectroscopy (MRS).
    Burneo JG, Knowlton RC, Faught E, Martin R, Sawrie S, Kuzniecky RI.
    Epilepsy Res; 2004 Dec 30; 62(2-3):119-24. PubMed ID: 15579300
    [Abstract] [Full Text] [Related]

  • 36. Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study.
    Galińska-Skok B, Małus A, Konarzewska B, Rogowska-Zach A, Milewski R, Tarasów E, Szulc A, Waszkiewicz N.
    Dis Markers; 2018 Dec 30; 2018():3654894. PubMed ID: 30595760
    [Abstract] [Full Text] [Related]

  • 37. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia.
    Cecil KM, Lenkinski RE, Gur RE, Gur RC.
    Neuropsychopharmacology; 1999 Feb 30; 20(2):131-40. PubMed ID: 9885793
    [Abstract] [Full Text] [Related]

  • 38. A proton magnetic resonance spectroscopy study in schizoaffective disorder: comparison of bipolar disorder and schizophrenia.
    Kalaycı D, Ozdel O, Sözeri-Varma G, Kıroğlu Y, Tümkaya S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr 27; 37(1):176-81. PubMed ID: 22306485
    [Abstract] [Full Text] [Related]

  • 39. N-acetylaspartate/creatine and choline/creatine ratios in the thalami, insular cortex and white matter as markers of hypertension and cognitive impairment in the elderly.
    Ben Salem D, Walker PM, Bejot Y, Aho SL, Tavernier B, Rouaud O, Ricolfi F, Brunotte F.
    Hypertens Res; 2008 Oct 27; 31(10):1851-7. PubMed ID: 19015591
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.